Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 215

Sort by

Sort Order Select

Journal Articles

Epigenetic Modulation of CD48 By NPM-ALK Promotes Immune Evasion in ALK+ ALCL

Rui Wu, MD PhD, Elena Ivan, MD, Anagh Anant Sahasrabuddhe, PhDMSc,BSc, Timothy Shaw, PhD, Charles G. Mullighan, MBBS, MD, Vasiliki Leventaki, Kojo S. J. Elenitoba-Johnson, MD, Megan S. Lim, MD PhD

Blood (2019) 134 (Supplement_1): 1510.

https://doi.org/10.1182/blood-2019-127453

Published: 2019

Journal Articles

DNA Cytosine-Demethylating Agent 5-Aza-2'-Deoxycytidine Targets Leukemia Cells through Reducing DNA N 6 -Methyladenine

Xiaochang Liu, PhD, Jiuxia Pang, Christopher Seiler, Ryan Kempen, Hao Liu, Aref Al-Kali, MD, Y. Natalia Tretyakova, Mark Litzow, MD, Shujun Liu

Blood (2019) 134 (Supplement_1): 2513.

https://doi.org/10.1182/blood-2019-130490

Published: 2019

Journal Articles

In Vivo Assessment of Intracellular Dynamics Comparing Injection Versus Oral Azacitidine in a Phase IIb Investigator Initiated Clinical Trial

Blood (2019) 134 (Supplement_1): 4247.

https://doi.org/10.1182/blood-2019-123921

Published: 2019

Journal Articles

Differential Genome-Wide Mutational Patterns in Indolent B-Cell Lymphomas

Julieta Haydee Sepulveda Yanez, MSc, Diego Alvarez, MSc, Jose Fernandez-Goycoolea, Cornelis A.M. van Bergen, PhD, Hendrik Veelken, MD PhD, Marcelo A. Navarrete, PhD

Blood (2018) 132 (Supplement 1): 4102.

https://doi.org/10.1182/blood-2018-99-116174

Published: 2018

Journal Articles

Selective Pressure from Chemotherapy Drives Convergent Evolution in Relapsing and Refractory AML across Age Groups

Timothy Junius Triche, Jr., PhD, Benjamin K. Johnson, PhD, Lyong Heo, MS, Yizhou Peter Huang, BS, Rhonda E. Ries, MA, Hamid Bolouri, PhD, Jason E. Farrar, MD, Soheil Meshinchi, MD PhD

Blood (2018) 132 (Supplement 1): 2609.

https://doi.org/10.1182/blood-2018-99-119323

Published: 2018

Journal Articles

Disulfiram May Contribute to Apoptosis of Myeloma Cells By Reactivating of Cell Cycle Regulating Gene CDKN2A

Denisa Hrckova Drozdkova, Jan Gursky, PhD, Petra Luzna, Sabina Sevcikova, PhD, Jiri Minarik, MD PhD, Katerina Smesny Trtkova, PhD

Blood (2018) 132 (Supplement 1): 5125.

https://doi.org/10.1182/blood-2018-99-114743

Published: 2018

Journal Articles

The Effect of TET Mutations on DNA Methyltransferase Cytotoxicity and ERV Induction in B and T Cell Malignancies

Juan Carlos Nogues, BS, Zi Michael Wang, BS, Sarah School Chisholm, MA, Mitcell Smith, MD PhD, Eduardo Sotomayor, MD, Katherine Chiappinelli, PhD

Blood (2018) 132 (Supplement 1): 5157.

https://doi.org/10.1182/blood-2018-99-120281

Published: 2018

Journal Articles

Protides of 5-Fluorotroxacitabine Display Potent Anti-Proliferative Properties and Circumvent Deoxycytidine Kinase-Mediated Resistance Associated with Cytotoxic Cytidine Analogues; A Novel Approach for Acute Myeloid Leukemia

Pedro Pinho, PhD, Helen Kylefjord, BSc, Vilma Rraklli, PhD, Christina Rydergård, BSc, Biljana Rizoska, PhD, Anders Eneroth, PhD, Johan Bylund, PhD, Sara Moses, PhD, Stefan Norin, MD PhD, Richard Bethell, PhD, Aniket Bankar, MBBS, MD DM, Thirushi Piyumika Siriwardena, Mark D. Minden, MD PhD, Aaron D Schimmer, MD PhD, Mark Albertella, PhD, Paul Targett-Adams, PhD BSc

Blood (2018) 132 (Supplement 1): 3497.

https://doi.org/10.1182/blood-2018-99-114440

Published: 2018

Journal Articles

Activation of T Cells Specific to Endogenous Retroviral Peptides: Possible Association with Clinical Response to Azacitidine in Myeloid Malignancies

Andreas Due Ørskov, Sunil Kumar Saini, Anne-Mette Bjerregaard, Hitoshi Otani, Staffan Holmberg, Jakob Werner Hansen, Marianne Bach Treppendahl, Anne Ortved Gang, Inge Høgh Dufva, Gangning Liang, Aron Charles Eklund, Peter A. Jones, Kirsten Grønbæk, Sine Reker Hadrup

Blood (2017) 130 (Supplement 1): 4243.

https://doi.org/10.1182/blood.V130.Suppl_1.4243.4243

Published: 2017

Journal Articles

Vitamin C Stabilizes Foxp3 Expression in Induced Treg Cells By Targeted DNA Demethylation and Prevents Murine Model of Acute Graft Versus Host Disease

Hidenori Kasahara, MD, Shinichiro Okamoto, MD PhD, Takashi Sekiya, PhD, Akihiko Yoshimura, PhD

Blood (2017) 130 (Supplement 1): 70.

https://doi.org/10.1182/blood.V130.Suppl_1.70.70

Published: 2017

Journal Articles

PD-1H (VISTA) Induces Immune Evasion in Acute Myeloid Leukemia

Tae Kon Kim, MD PhD, Xue Han, PhD, Jun Wang, PhD, Miguel Sanmamed, MD, Tianxiang Zhang, PhD, Stephanie Halene, MD PhD, Manoj M Pillai, MD, Jun Lu, PhD, Mina Xu, MD, Amer M. Zeidan, MD, Steven D. Gore, MD, Madhav V Dhodapkar, MBBS, Lieping Chen, MD PhD

Blood (2017) 130 (Supplement 1): 2658.

https://doi.org/10.1182/blood.V130.Suppl_1.2658.2658

Published: 2017

Journal Articles

The Mutation Landscape of Follicular Lymphoma and Chronic Lymphocytic Leukemia Reveals a Distinctive Frequency and Composition of Aid-Related Mutation Signatures

Julieta Sepulveda, MSc, Cornelis A.M. van Bergen, PhD, Diego Alvarez, MSc, Szymon Kielbasa, PhD, Hailiang Mei, PhD, Hendrik Veelken, MD PhD, Marcelo Navarrete Signorile, MD PhD

Blood (2017) 130 (Supplement 1): 2741.

https://doi.org/10.1182/blood.V130.Suppl_1.2741.2741

Published: 2017

Journal Articles

Effective Treatment of Low-Doses Decitabine in Myelodysplastic Syndrome / Myeloproliferative Neoplasms with JAK2/V617F

Huang Jian, MDPhD, Xingnong Ye, Chen DAN, Xiaoqiong Zhu, Junkai FU, Yan Zheng, MD PhD

Blood (2017) 130 (Supplement 1): 5279.

https://doi.org/10.1182/blood.V130.Suppl_1.5279.5279

Published: 2017

Journal Articles

Ten-Day Decitabine Treatment in AML Associated with Reversible Non-Ischemic Cardiomyopathy

Bhavisha Patel, MD, Barac Ana, MD, Kelly W. Fitzpatrick, MD, Aarthi Shenoy, MD

Blood (2017) 130 (Supplement 1): 5032.

https://doi.org/10.1182/blood.V130.Suppl_1.5032.5032

Published: 2017

Journal Articles

Decitabine As Hemoglobin F Inducer in Hemoglobin E/β Thalassemia

Siddhesh Arun Kalantri, MDMDcine, Rudra Ray, M.Sc, Arnab Chattopadhyay, MDPathology, Maitreyee Bhattacharyya, DM

Blood (2017) 130 (Supplement 1): 2224.

https://doi.org/10.1182/blood.V130.Suppl_1.2224.2224

Published: 2017

Journal Articles

Low-Level SAMHD1 Expression in Acute Myeloid Leukemia Blasts Correlates with Favorable Outcome in Patients with Diploid Cytogenetics Treated with Cytarabine-Based Chemotherapy Regimens

George Rassidakis, MD PhD, Herold Nikolas, MD PhD, Ida Hed Hed Myrberg, PhD, Nikolaos Tsesmetzis, MSc., Dan Grander, MD PhD, Hagop M. Kantarjian, MD, L. Jeffrey Medeiros, MD, Ioanna Xagoraris, MD, Joseph David Khoury, MD

Blood (2017) 130 (Supplement 1): 3928.

https://doi.org/10.1182/blood.V130.Suppl_1.3928.3928

Published: 2017

Journal Articles

Phase 1 Evaluation of Oral Tetrahydrouridine-Decitabine As Non-Cytotoxic Epigenetic Disease Modification for Sickle Cell Disease

Robert E Molokie, MD, Donald Lavelle, PhD, Michel Gowhari, DO, Michael Pacini, PharmD, Lani Krauz, Johara Hassan, MD, Vinzon Ibanez, Maria A Ruiz, Daisy Pacelli, Sherry Fada, Mitch A. Phelps, PhD, Santosh L. Saraf, MD, Lewis L. Hsu, MD PhD, Victor R. Gordeuk, MD, Joseph DeSimone, PhD, Yogenthiran Saunthararajah, MD

Blood (2016) 128 (22): 124.

https://doi.org/10.1182/blood.V128.22.124.124

Published: 2016

Journal Articles

Elevated Pre-Treatment Fetal Hemoglobin Predicts Better Outcome in MDS/AML Patients Receiving 5-Aza-2'-Deoxycytidine (DAC)

Rainer Claus, MD, Gabriele Ihorst, PhD, Philipp Sander, Ljudmila Bogatyreva, Heiko Becker, MD, Pierre W Wijermans, MD, Stefan Suciu, Emmanuel Bissé, MD PhD, Michael Lübbert, MD

Blood (2016) 128 (22): 3175.

https://doi.org/10.1182/blood.V128.22.3175.3175

Published: 2016

Journal Articles

Synergistic Lethality with Gemcitabine and Arsenic Trioxide Against Human T Cell Lymphoma Jurkat Cells

Mingwan Zhang, MD, Xiaojun Xu, MD PhD, Yongbin Ye, MD PhD, Qifa Liu

Blood (2016) 128 (22): 5383.

https://doi.org/10.1182/blood.V128.22.5383.5383

Published: 2016

Journal Articles

Suppression of Mir-708 Promotes DKK3 to Inhibit Wnt/β-Catenin Signaling Pathway in Adult B-ALL

Yingjie Zhang, Huibo Li, Rongyi Cao, Lili Sun, Yan Wang, Shengjin Fan, Yanqiu Zhao, Desheng Kong, Lin Cui, Leilei Lin, Ke Wang, Chen Wang, Yinghua Li, Jin Zhou, MD PhD

Blood (2016) 128 (22): 5090.

https://doi.org/10.1182/blood.V128.22.5090.5090

Published: 2016

NARROW

Epigenetic Modulation of CD48 By NPM-ALK Promotes Immune Evasion in ALK+ ALCL

DNA Cytosine-Demethylating Agent 5-Aza-2'-Deoxycytidine Targets Leukemia Cells through Reducing DNA N 6 -Methyladenine

In Vivo Assessment of Intracellular Dynamics Comparing Injection Versus Oral Azacitidine in a Phase IIb Investigator Initiated Clinical Trial

Differential Genome-Wide Mutational Patterns in Indolent B-Cell Lymphomas

Selective Pressure from Chemotherapy Drives Convergent Evolution in Relapsing and Refractory AML across Age Groups

Disulfiram May Contribute to Apoptosis of Myeloma Cells By Reactivating of Cell Cycle Regulating Gene CDKN2A

The Effect of TET Mutations on DNA Methyltransferase Cytotoxicity and ERV Induction in B and T Cell Malignancies

Protides of 5-Fluorotroxacitabine Display Potent Anti-Proliferative Properties and Circumvent Deoxycytidine Kinase-Mediated Resistance Associated with Cytotoxic Cytidine Analogues; A Novel Approach for Acute Myeloid Leukemia

Activation of T Cells Specific to Endogenous Retroviral Peptides: Possible Association with Clinical Response to Azacitidine in Myeloid Malignancies

Vitamin C Stabilizes Foxp3 Expression in Induced Treg Cells By Targeted DNA Demethylation and Prevents Murine Model of Acute Graft Versus Host Disease

PD-1H (VISTA) Induces Immune Evasion in Acute Myeloid Leukemia

The Mutation Landscape of Follicular Lymphoma and Chronic Lymphocytic Leukemia Reveals a Distinctive Frequency and Composition of Aid-Related Mutation Signatures

Effective Treatment of Low-Doses Decitabine in Myelodysplastic Syndrome / Myeloproliferative Neoplasms with JAK2/V617F

Ten-Day Decitabine Treatment in AML Associated with Reversible Non-Ischemic Cardiomyopathy

Decitabine As Hemoglobin F Inducer in Hemoglobin E/β Thalassemia

Low-Level SAMHD1 Expression in Acute Myeloid Leukemia Blasts Correlates with Favorable Outcome in Patients with Diploid Cytogenetics Treated with Cytarabine-Based Chemotherapy Regimens

Phase 1 Evaluation of Oral Tetrahydrouridine-Decitabine As Non-Cytotoxic Epigenetic Disease Modification for Sickle Cell Disease

Elevated Pre-Treatment Fetal Hemoglobin Predicts Better Outcome in MDS/AML Patients Receiving 5-Aza-2'-Deoxycytidine (DAC)

Synergistic Lethality with Gemcitabine and Arsenic Trioxide Against Human T Cell Lymphoma Jurkat Cells

Suppression of Mir-708 Promotes DKK3 to Inhibit Wnt/β-Catenin Signaling Pathway in Adult B-ALL

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only